Expert-Led Assessment Services for Strategic Acquisitions and Partnerships
To know more about the rules,
Please Fill the Form
To learn more, connect with us
Indian medical device manufacturers aiming to enter the UK market following the post-Brexit transition, obtaining UKCA certification is a significant challenge. Adhering to the requirements outlined in The Medical Device Regulations 2002 (SI 2002 No. 618, as amended) (UK MDR) is a crucial step in ensuring compliance and successful product launch. This compliance process serves as the foundation for regulatory due diligence, enabling Indian manufacturers to meet UK standards and market their devices effectively.
At CliniExperts, we specialize in conducting in-depth UKCA regulatory due diligence tailored specifically for Indian manufacturers. Our services are built to provide a full-spectrum compliance risk assessment—covering route selection, technical documentation, QMS, post-market surveillance, and facility readiness.
Preparing and reviewing product documentation to ensure it meets UKCA marking requirements.
Identifying potential non-conformities that may lead to product withdrawal or Notified Body rejection.
Verifying QMS compliance with ISO 13485:2016 and MDR Article 10 obligations.
Exposing gaps in PMS/PSUR, CAPA handling, and vigilance systems that may impact valuation.
Entering the UK market or acquiring a UK manufacturer demands far more than financial feasibility and product portfolio alignment. Regulatory Due Diligence is the gatekeeper to assessing the true operational and commercial value of the target.
Comprehensive evaluation of certificates, scope, and conformity routes
Assessment of technical files, clinical evaluations, and risk management
Analysis of labeling, IFUs, and claims substantiation
Verification of ISO 13485:2016 compliance and MDR readiness
Review of vigilance systems and field safety procedures
Assessment of regulatory correspondence and certification status
Evaluate certificates, scope, expiration, and conformity routes based on multiple factors.
Assess alignment of the product classification and GMDN coding.
Review any conditions imposed by the Regulatory Body.
Evaluate documentation as per UK MDR 2002
Assess clinical evaluation data and risk management files.
Post market Surveillance documentation.
Assess language requirements, UDI implementation, and claims substantiation.
Check traceability elements and alignment with UDI-DI (if applicable).
Analyze labeling and IFUs for compliance with Annex I, Chapter III of EU MDR.
Audit facility compliance with international standards.
Assess internal practices and management review efficacy.
Evaluate readiness for unannounced audits.
Audit facility compliance with ISO 13485:2016 and MDR Article 10. Assess internal audit practices, management review efficacy, and document controls. Evaluate readiness for unannounced audits and Notified Body inspections.
Review PSURs, PMS reports, vigilance history, and trend analysis records.
Evaluate Field Safety Corrective Actions (FSCA) and incident investigation quality.
Assess integration with MORE Portal.
CliniExperts is your strategic partner for technical and regulatory due diligence in EU device transactions. We empower Indian manufacturers with precision insight to navigate the European regulatory landscape confidently.